Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Delivra Health Brands Inc V.DHB

Alternate Symbol(s):  DHBUF

Delivra Health Brands Inc. is a Canada-based consumer packaged goods company. The Company provides products that help with pain, sleep, anxiety, and performance through its acquired brands LivRelief and Dream Water. It operates a portfolio of brands under its Consumer Division consisting of Dream Products Inc. and its associated subsidiaries, and Delivra Corp. and its associated subsidiaries. Dream Water produces convenient, travel-friendly, single-serving 2.5oz liquid sleep shots, sleep powder packets that consumers can take with or without water and gummies. Its LivRelief brand offers relief for conditions such as joint and muscle pain, nerve pain, varicose veins, wound healing, and sports performance. It has also added three new products to its portfolio of licensed infused products: Transdermal 1:1 Cream- 250mg CBD:250mg THC; Transdermal CBD Cream with Cooling - 500mg CBD, and Extra Strength Transdermal CBD Cream: 1200mg CBD.


TSXV:DHB - Post by User

Bullboard Posts
Comment by Lincoln9on Feb 26, 2019 6:13pm
94 Views
Post# 29416844

RE:RE:Grant Froese made the biggest insider purchase

RE:RE:Grant Froese made the biggest insider purchaseI think he's refering to July 23rd and 25th, 

page2image1955244064DEEMED INSIDER

Providing Insider News and Knowledge to Investors

page2image1955251552page2image1955251760page2image1955251968page2image1955252240page2image1955252512page2image1955179200page2image1955179408page2image1955179616

page2image1955180560CEO / page2image1955181536CFO / page2image1955182544OTHER OFFICER / page2image1955184224DIRECTOR / page2image1955185808ISSUER / page2image195518710410% HOLDER / page2image1955188528SUBSIDIARY EXECUTIVE - Information that has been adjusted or estimated by INK - Amended filing

All data based on insider regulatory filings which are subject to input errors.

page2image1955201728page2image1955201936
page2image1955204528 page2image1955248592 page2image1955249152page2image1955205824page2image1955206016page2image1955206208page2image1955206464page2image1955206720 page2image1955207024

Transaction
Date Insider Name Ownership Type Nature of Transaction page2image1955213072page2image1955213392Security page2image1955214416Price ($) Units Change* Account Balance

Shares/ Account

page2image1955219808 page2image1955220368page2image1955221232page2image1955221424 page2image1955221680page2image1955221936
page2image1955226496

Nov 20/18 MMJ PhytoTech Limited Indirect Ownership Private sale Common Shares 0.00 -166,534 -0.3% 49,734,823

page2image1955242352

Nov 20/18 MMJ PhytoTech Limited Indirect Ownership Private buy Common Shares 0.840 8,326,695 20.0% 49,901,357

page2image1955398816

Nov 16/18 MMJ PhytoTech Limited Direct Ownership Public market sale Common Shares 0.500 -76,500 -1.3% 5,823,171

page2image1955414768

Nov 15/18 MMJ PhytoTech Limited Direct Ownership Public market sale Common Shares 0.501 -216,500 -3.5% 5,899,671

page2image1955430720

Nov 14/18 MMJ PhytoTech Limited Direct Ownership Public market sale Common Shares 0.500 -2,000 0.0% 6,116,171

page2image1955446864

Nov 13/18 MMJ PhytoTech Limited Direct Ownership Public market sale Common Shares 0.514 -276,500 -4.3% 6,118,171

page2image1955462832

Nov 12/18 MMJ PhytoTech Limited Direct Ownership Public market sale Common Shares 0.550 -500 0.0% 6,394,671

page2image1955477904

Nov 9/18 MMJ PhytoTech Limited Direct Ownership Public market sale Common Shares 0.556 -230,000 -3.5% 6,395,171

page2image1955493792

Nov 8/18 MMJ PhytoTech Limited Direct Ownership Public market sale Common Shares 0.600 -27,000 -0.4% 6,625,171

page2image1858423504

Nov 7/18 MMJ PhytoTech Limited Direct Ownership Public market sale Common Shares 0.600 -106,500 -1.6% 6,652,171

page2image1936820304

Oct 25/18 MMJ PhytoTech Limited Direct Ownership Public market sale Common Shares 0.570 -881,000 -11.5% 6,758,671

page2image1936819104

Oct 24/18 MMJ PhytoTech Limited Direct Ownership Public market sale Common Shares 0.588 -1,970,000 -20.5% 7,639,671

page2image1937149232

Oct 23/18 MMJ PhytoTech Limited Direct Ownership Public market sale Common Shares 0.573 -1,069,000 -10.0% 9,609,671

page2image1858843184

Oct 22/18 MMJ PhytoTech Limited Direct Ownership Public market sale Common Shares 0.652 -836,500 -7.3% 10,678,671

page2image1937227120

Oct 19/18 MMJ PhytoTech Limited Direct Ownership Public market sale Common Shares 0.755 -243,500 -2.1% 11,515,171

page2image1858725264

Sep 18/18 Holler, Frank Direct Ownership Opening report Options 0.00 300,000 n/a 300,000

page2image1937163152

Jul 25/18 Froese, Grant Bernard Direct Ownership Public market buy Common Shares 0.700 132,000 > 100% 143,000

page2image1858322064

Jul 23/18 Froese, Grant Bernard Direct Ownership Public market buy Common Shares 0.700 11,000 > 100% 11,000

page2image1937342368

Jul 3/18 Froese, Grant Bernard Direct Ownership Opening report Common Shares 0.00 0 n/a 0

page2image1937357168

Jul 3/18 Froese, Grant Bernard Direct Ownership Opening report Performance Appreciation Rights 0.00 1,790,000 n/a 1,790,000

page2image1937373840

Jul 3/18 Froese, Grant Bernard Direct Ownership Opening report Options 0.00 5,710,000 n/a 5,710,000

page2image1937388208

Jul 3/18 Kain, Andrew Malcolm Direct Ownership Opening report Performance Appreciation Rights 0.00 710,000 n/a 710,000

page2image1937404928

Jul 3/18 Kain, Andrew Malcolm Direct Ownership Opening report Options 0.00 2,290,000 n/a 2,290,000

 to July 23 and 25 2018.

Bullboard Posts